Connection

Paul O'Brien to Doxorubicin

Back to Details
This is a "connection" page, showing publications Paul O'Brien has written about Doxorubicin.
Paul O'Brien
Connection Strength
0.088
Doxorubicin
  1. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.